Kesh Naidoo-Rauf Key policy changes for community pharmacy and APP reflections This year is flying by, with key policy changes for community pharmacy implemented in New Zealand and the opportunity to catch up with our Australian colleagues and continue to learn from each other. ... 12-month prescriptions Advocacy Pharmacy ownership Apr 30, 2026
Andrew Gaudin Progress made in 2025 Positively influence pending legislative, regulatory and policy change Delivered full mitigation of the potential adverse fee impacts of 12-month prescriptions from 1 February 2026 – avoiding a mid-po... 12-month prescriptions Advocacy Funding NAAR Jan 31, 2026
Kesh Naidoo-Rauf Our priorities for 2026 Our purpose has always been clear: to support and advance the business and professional needs of community pharmacy. At the heart of this is our commitment to promote, protect, and strengthen the coll... 12-month prescriptions Advocacy Constitution Funding Pharmacy ownership Scope of practice Workforce Dec 31, 2025
Andrew Gaudin 12-month prescription mitigation We have worked intensely with key senior officials to resolve this issue since the government’s policy decision in May 2025. This has included working with officials at multiple levels and providing r... 12-month prescriptions Advocacy Funding NAAR Nov 30, 2025
Nicole Rickman Media release: Guild successfully mitigates 12-month prescription impacts The Pharmacy Guild of New Zealand (the Guild) is delighted that Health New Zealand (HNZ) has now agreed to funding changes to fully mitigate the financial impact of 12-month prescriptions for communit... 12-month prescriptions Funding Media release Nov 12, 2025
Andrew Gaudin Decision to allow 12-month prescriptions The Guild first became aware of this policy proposal in October 2024, when we provided significant feedback on the impacts for patients, community pharmacies and the broader healthcare system. Some of... 12-month prescriptions Advocacy Funding Jun 30, 2025